Advertisement

Racial and Ethnic Influences on the Expression of the Genotype in Neurodegenerative Diseases

  • Katrina Gwinn-Hardy
Conference paper
Part of the Research and Perspectives in Alzheimer's Disease book series (ALZHEIMER)

Keywords

Frontotemporal Dementia Spinocerebellar Ataxia Jewish Woman Spinocerebellar Ataxia Type Presenilin Mutation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Azuonye IO (1996) Guidelines will encourage the thinking that underpins racism in medicine. Brit Med J 313:426.Google Scholar
  2. Balter M, Gibbons A (2000) Paleoanthropology. A glimpse of humans' first journey out of Africa. Science 288: 948–950.CrossRefPubMedGoogle Scholar
  3. Beckman LE, Saha N, Spitsyn V, Van Landeghem G, Beckman L (1997) Ethnic differences in the HFE codon 282 (Cys/Tyr) polymorphism. Human Hered 47:263–267.Google Scholar
  4. Bogue G, Edwards GF (1971) How to get along without race in demographic analysis. Soc Biol 18:387–396.PubMedGoogle Scholar
  5. Bradley WG, Daroff RB Fenichel GM, Marsden CD (1991) Neurology in clinical practice. The neurological disorders. Volume II. Butterworth-Heinemann, Boston, p. 1417.Google Scholar
  6. Brennan P (1999) Design and analysis issues in case-control studies addressing genetic susceptibility. IARC Sci Publ 148:123–132.PubMedGoogle Scholar
  7. Burke JR, Wingfield MS, Lewis KE, Roses AD, Lee JE, Hulette C, Pericak-Vance MA, Vance JM (1994) The Haw River syndrome: dentatorubropallidoluysian atrophy (DRPLA) in an African-American family. Nature Genet 7:521–524.CrossRefPubMedGoogle Scholar
  8. Chung MY, Lu YC, Cheng NC, Soong BW (2003) A novel autosomal dominant spinocerebellar ataxia (SCA22) linked to chromosome 1p21–q23. Brain 126:1293–1299CrossRefPubMedGoogle Scholar
  9. Editorial (2000) Census, race and science. Nature Genet 24:97–98.Google Scholar
  10. Estrada R, Galarraga J, Orozco G, Nodarse A, Auburger G (1999) Spinocerebellar ataxia 2 (SCA2): morphometric analyses in 11 autopsies. Acta Neuropathol (Berl) 97:306–310.CrossRefPubMedGoogle Scholar
  11. Flores G, Fuentes-Afflick E, Carter-Pokras O, Claudio L, Lamberty G, Lara M, Pachter L, Ramos Gomez F, Mendoza F, Valdez RB, Zambrana RE, Greenberg R, Weitzman M. (2001) Why ethnicity and race are so important in child health services research today. Arch Pediatr Adolesc Med 155:1178–1179.PubMedGoogle Scholar
  12. Foster NL, Wilhelmsen K, Sima AA, Jones MZ, D'Amato CJ, Gilman S (1997) Frontotemporal dementia and parkinsonism linked to chromosome 17: a consensus conference. Conference Participants. Ann Neurol 41:706–715.CrossRefPubMedGoogle Scholar
  13. Fullilove MT (1998) Comment: abandoning “race” as a variable in public health research: an idea whose time has come. Am J Publ Health 88:1297–1298.Google Scholar
  14. Friedman LM, Furberg CD, DeMets, DL, eds (1998) Fundamentals of Clinical Trials. 3rd edition. Springer, New York.Google Scholar
  15. Furtado S, Farrer M, Tsuboi Y, Klimek ML, de las Fuente-Fernandez R, Hussey J, Lockhardt P, Calne DB, Suchowersky O, Stoessl AJ, Wszolek Z (2002). SCA-2 presenting as parkinsonism in an Alberta family: clinical, genetic and PET findings. Neurology 59:1625–1627.PubMedGoogle Scholar
  16. Gwinn-Hardy K, Chen, JY, Liu H.-C, Liu TY, Boss M, Seltzer W, Adam A, Singleton A, Koroshetz W, Waters C. Hardy J. Farrer M (2000) Spinocerebellar ataxia type 2 with parkinsonism in ethnic Chinese. Neurology 55: 800–805.PubMedGoogle Scholar
  17. Gwinn-Hardy K, Singleton A, O'Suilleabhain P, Boss M, Nicholl D, Adam A, Hussey J, Critchley P, Hardy J, Farrer M (2001) Spinocerebellar ataxia type 3 phenotypically resembling Parkinson disease in a black family. Arch Neurol; 58:296–299.CrossRefPubMedGoogle Scholar
  18. Hardy J, Singleton A, Gwinn-Hardy K (2003) Ethnic differences and disease phenotypes. Science 300:739–740.CrossRefPubMedGoogle Scholar
  19. Hussey J, Lockhart PJ, Seltzer W, Wszolek ZK, Payami H, Hanson M, Gwinn-Hardy K, Farrer M (2002) Accurate determination of ataxin-2 polyglutamine expansion in patients with intermediate-range repeats. Genet Test 6:217–220.CrossRefPubMedGoogle Scholar
  20. Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H, Pickering-Brown S, Chakraverty S, Isaacs A, Grover A, Hackett J, Adamson J, Lincoln S, Dickson D, Davies P, Petersen RC, Stevens M, de Graaff E, Wauters E, van Baren J, Hillebrand M, Joosse M, Kwon JM, Nowotny P, Che LK, Norton J, Morris JC., Reed LA, Trojanowski J, Basun H, Lannfelt L, Neystat M, Fahn S, Dark F, Tannenberg T, Dodd PR, Hayward N, Kwok JBJ, Schofield PR, Andreadis A, Snowden J, Craufurd D, Neary D, Owen F, Oostra BA, Hardy J, Goate A, van Swieten J, Mann D, Lynch T, Heutink P. (1998) Coding and splice donor site mutations in tau cause autosomal dominant dementia (FTDP-17). Nature 393:702–705.CrossRefPubMedGoogle Scholar
  21. Iannuzzi MC, Maliarik M, Rybicki B (2002) Genetic polymorphisms in lung disease: bandwagon or breakthrough? Resp Res 3:15:1186.Google Scholar
  22. Kelly J (2004) Answer man: the word on science. Washington Post, Monday, September 6, C11.Google Scholar
  23. Kock N, Muller B, Vieregge P, Pramstaller PP, Marder K, Abbruzzese G, Martinelli P, Lang AE, Jacobs H, Hagenah J, Harris J, Meija-Santana H, Fahn S, Hedrich K, Kann M, Gehlken U, Culjkovic B, Schwinger E, Wszolek ZK, Zuhlke C, Klein C (2002) Role of SCA2 mutations in early-and late-onset dopa-responsive parkinsonism. Ann Neurol 52: 257–258.CrossRefPubMedGoogle Scholar
  24. Krieger N, Williams D, Zierler S (1999) “Whiting out” white privilege will not advance the study of how racism harms health. Am J Publ Health 89:782–783.Google Scholar
  25. LaVeist TA (1996) Why we should continue to study race — but do a better job: an essay on race, racism and health. Ethn Dis 6:21–29.PubMedGoogle Scholar
  26. Lehmann LS, Weeks JC, Klar N, Garber JE (2002) A population-based study of Ashkenazi Jewish women's attitudes toward genetic discrimination and BRCA1/2 testing. Genet Med 4:346–352.PubMedGoogle Scholar
  27. Lu CS, Wu Chou YH, Yen TC, Tsai CH, Chen RS, Chang HC (2002) Dopa-responsive parkinsonism phenotype of spinocerebellar ataxia type 2. Mov Disord 17:1046–1051.CrossRefPubMedGoogle Scholar
  28. McInerney-Leo A, Gwinn-Hardy K, Nussbaum RL (2004) Prevalence of Parkinson's disease in populations of African ancestry: a review. J Natl Med Assoc 96:974–979.PubMedGoogle Scholar
  29. Nagafuchi S, Yanagisawa H, Sato K, Shirayama T, Ohsaki E, Bundo M, Takeda T, Tadokoro K, Kondo I, Murayama N, Tanaka Y, Kikushima H, Umino K, Kurosawa H, Furukawa T, Nihei K, Inoue T, Sano A, Komure O, Takahashi M, Yoshizawa T, Kanazawa I, Yamada M (1994) Dentatorubral and pallidoluysian atrophy expansion of an unstable CAG trinucleotide on chromosome 12p. Nature Genet 6:14–18.CrossRefPubMedGoogle Scholar
  30. Perera, FP (1997) Environment and cancer: who are susceptible? Science 278: 1068–1073.CrossRefPubMedGoogle Scholar
  31. Pulst SM, Nechiporuk A, Nechiporuk T, Gispert S, Chen X-N, Lopes-Cendes I, Pearlman S, Starkman S, Orozco-Diaz G, Lunkes A, DeJong P, Rouleau GA, Auburger G, Korenberg JR, Figueroa C, Sahba S (1996) Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2. Nature Genet 14: 269–276.CrossRefPubMedGoogle Scholar
  32. Rippon G, Baker M, Crook R, Hutton M, Hardy J, Lynch T (2003) An African American family with a presenilin mutation. Arch Neurol 60:884–888.CrossRefPubMedGoogle Scholar
  33. Risch N, Burchard E, Ziv E, Tang H (2002) Categorization of humans in biomedical research: genes, race and disease. Genome Biol 1;3: comment 2007. Epub Jul 01, 2002Google Scholar
  34. Rosenberg, RN, Fowler, HL (1981) Autosomal dominant motor system disease of the Portuguese: a review. Neurology 31:1124–1126.PubMedGoogle Scholar
  35. Rosenberg NA, Pritchard JK, Weber JL, Cann HM, Kidd KK, Zhivotovsky LA, Feldman MW (2002) Genetic structure of human populations. Science 298:2381–2385.CrossRefPubMedGoogle Scholar
  36. Sanpei K, Takano H, Igarashi S, Sato T, Oyake M, Sasaki H, Wakisaka A, Tashiro K, Ishida Y, Ikeuchi T, Koide R, Saito M, Sato A, Tanaka T, Hanyu S, Takiyama Y, Nishizawa M, Shimizu N, Nomura Y, Segawa M, Iwabuchi K, Eguchi I, Tanaka H, Takahashi H, Tsuji S (1996) Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT. Nature Genet 14:277–284.CrossRefPubMedGoogle Scholar
  37. Schmitt E (2001) For 7 million people in census, one race category isn't enough. New York Times. March 13, 2001:1.Google Scholar
  38. Schols L, Gispert S, Vorgerd M, Menezes Vieira-Saecker AM, Blanke P, Auburger G, Amoiridis G, Meves S, Epplen JT, Przuntek H, Pulst SM, Riess O (1997) Spinocerebellar ataxia type 2. Genotype and phenotype in German kindreds. Arch Neurol 54:1073–1080.PubMedGoogle Scholar
  39. Schwartz RS (2001) Racial profiling in medical research N Engl J Med. 18:1392–1393.CrossRefGoogle Scholar
  40. Shan D-E, Soong B-W, Sun C-M, Lee S-J, Liao K-K, Liu R-S (2001) Spinocerebellar ataxia type 2 presenting as familial levodopa-responsive parkinsonism. Ann Neurol 50:812–815.CrossRefPubMedGoogle Scholar
  41. Soong B, Cheng C, Liu R, Shan D (1997) Machado-Jospeh disease: clinical, molecular, and metabolic characterization in Chinese kindreds. Ann Neurol 41: 446–452.CrossRefPubMedGoogle Scholar
  42. Spillantini MG, Bird TD, Ghetti B (1998) Frontotemporal dementia and Parkinsonism linked to chromosome 17: a new group of tauopathies. Brain Pathol 8:387–402PubMedGoogle Scholar
  43. Srinivasan S, Guillermo T (2000) Toward improved health: disaggregating Asian American and Native Hawaiian/Pacific Islander data. Am J Publ Health 90:1731–1734.Google Scholar
  44. Subramony SH, Hernandez D, Adam A, Smith-Jefferson S, Hussey J, Gwinn-Hardy K, Lynch T, McDaniel O, Hardy J, Farrer M, Singleton A (2002) Ethnic differences in the expression of neurodegenerative disease: Machado-Joseph disease in Africans and Caucasians. Mov Disord 17:1068–1071.CrossRefPubMedGoogle Scholar
  45. Terris M (1973) Desegregating health statistics. Am J Publ Health 63:477–480.Google Scholar
  46. Tuite PJ, Rogaeva EA, St George-Hyslop PH, Lang AE (1995) Dopa-responsive parkinsonism phenotype of Machado-Joseph disease: confirmation of 14q CAG expansion. Ann Neurol 38:684–687.CrossRefPubMedGoogle Scholar
  47. Wacholder S, Rothman N, Caporaso N (2000) Population stratification in epidemiologic studies of common genetic variants and cancer: quantification of bias. J Natl Cancer Inst. 92:1151–1158.CrossRefPubMedGoogle Scholar
  48. Warrington EK, Agnew SK, Kennedy AM, Rossor MN (2001) Neuropsychological profiles of familial Alzheimer's disease associated with mutations in the presenilin 1 and amyloid precursor protein genes. J Neurol 248:45–50.CrossRefPubMedGoogle Scholar
  49. Williams DR (1997) Race and health: basic questions, emerging directions. Ann Epidemiol 7:322–333.CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2005

Authors and Affiliations

  • Katrina Gwinn-Hardy
    • 1
  1. 1.National Institute of Neurological Disorders and StrokeNational Institutes of HealthBethesdaUSA

Personalised recommendations